đŹ Current Disease Focus:
Task Progress: 0%
đ„ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
đ§Ș Experimental Design
đŹ Clinical Trials
đ Treatment Development
This was an open-label, multicenter, single-arm, Phase II trial of bevacizu...
Status
Completed
Location
Multiple Locations
Start Date
2006-03
Trial ID
NCT00312728
Treatments Being Tested
This randomized phase III trial studies chemotherapy and bevacizumab to see...
Status
Completed
Location
Northeast Alabama Regional Medical Center
Start Date
2007-07-19
Trial ID
NCT00324805
The purpose of this study is to determine whether a combination of the drug...
Status
Completed
Location
Memorial Sloan-Kettering at Basking Ridge
Start Date
2008-05
Trial ID
NCT00675597
Treatments Being Tested
This single arm genetic substudy of MO19390 will test the hypothesis that t...
Status
Terminated
Location
Multiple Locations
Start Date
2007-05
Trial ID
NCT00642824
Treatments Being Tested
The purpose of this study is to evaluate a novel neoadjuvant regimen for in...
Status
Unknown
Location
Hospital Auxilio Mutuo Cancer Center
Start Date
2011-03
Trial ID
NCT01641406
This trial will evaluate whether the sequential administration of Cisplatin...
Status
Completed
Location
University General Hospital of Alexandroupolis, Dep of Medical Oncology
Start Date
2008-01
Trial ID
NCT00620971
Treatments Being Tested
Open label multicentric phase II randomized trial, using high throughput ge...
Status
Active Not Recruiting
Location
Institut de Cancérologie de l'Ouest/Paul Papin
Start Date
2014-04-07
Trial ID
NCT02299999
The hypothesize is that tepotinib is more effective than the investigator's...
Status
Recruiting
Location
Besançon - CHU
Start Date
2025-12-09
Trial ID
NCT06908993
Our hypothesis is that this study design, in which bevacizumab is added to ...
Status
Terminated
Location
Palm Beach Cancer Center Institute
Start Date
2007-05
Trial ID
NCT00476827
Treatments Being Tested
This phase III, multicenter, randomized, placebo-controlled, blinded trial ...
Status
Completed
Location
Multiple Locations
Start Date
2006-02
Trial ID
NCT00281697
Treatments Being Tested